Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GOTTESDIENER K")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

A new VSG expression site-associated gene (ESAG) in the promoter region of Trypanosoma brucei encodes a protein with 10 potential transmembrane domainsGOTTESDIENER, K. M.Molecular and biochemical parasitology. 1994, Vol 63, Num 1, pp 143-151, issn 0166-6851Article

ALDOSTERONE RESPONSE TO PROLONGED ACTH INFUSION IN JUVENILE HYPERTENSIONRAUH W; GOTTESDIENER K; CHOW D et al.1980; PEDIATR. RES.; ISSN 0031-3998; USA; DA. 1980; VOL. 14; NO 9; PP. 1035-1039; BIBL. 38 REF.Article

6BETA -HYDROXYCORTISOL EXCRETION IN HYPERCORTISOLEMIC STATESVOCCIA E; SAENGER P; PETERSON RE et al.1979; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1979; VOL. 48; NO 3; PP. 467-471; BIBL. 29 REF.Article

A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in miceMUTOMBA, M. C; FENGSHENG LI; GOTTESDIENER, K. M et al.Experimental parasitology. 1999, Vol 91, Num 2, pp 176-184, issn 0014-4894Article

Trypanosoma brucei brucei : Characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithineLI, F; HUA, S.-B; WANG, C. C et al.Experimental parasitology. 1998, Vol 88, Num 3, pp 255-257, issn 0014-4894Article

Chromosome organization of the protozoan Trypanosoma bruceiGOTTESDIENER, K; GARCIA-ANOVEROS, J; MARY GWO-SHU LEE et al.Molecular and cellular biology (Print). 1990, Vol 10, Num 11, pp 6079-6083, issn 0270-7306, 5 p.Article

Predicted amino acid sequence and genomic organization of Trypanosoma cruzi hsp 60 genesGIAMBIAGI-DE MARVAL, M; GOTTESDIENER, K; RONDINELLI, E et al.Molecular and biochemical parasitology. 1993, Vol 58, Num 1, pp 25-31, issn 0166-6851Article

A proposed mechanism for promoter-associated DNA rearrangement events at a variant surface glycoprotein gene expression siteGOTTESDIENER, K. M; LAKSHMI GORIPARTHO; MASUCCI, J. P et al.Molecular and cellular biology (Print). 1992, Vol 12, Num 10, pp 4784-4795, issn 0270-7306Article

Alpha-amanitin resitant transcription of protein coding genes in insect and bloodstream form Trypanosoma bruceiRUDENKO, G; BISHOP, D; GOTTESDIENER, K et al.EMBO journal (Print). 1989, Vol 8, Num 13, pp 4259-4263, issn 0261-4189Article

Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activationGOTTESDIENER, K. M; KARPINSKI, B. A; LINDSTEN, T et al.Molecular and cellular biology (Print). 1988, Vol 8, Num 9, pp 3809-3819, issn 0270-7306Article

Effect of L-000845704, an αvβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic womenMURPHY, M. G; CERCHIO, K; STOCH, S. A et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 4, pp 2022-2028, issn 0021-972X, 7 p.Article

Structure, expression and regulation of the murine 4F2 heavy chainPARMACEK, M. S; KARPINSKI, B. A; GOTTESDIENER, K. M et al.Nucleic acids research. 1989, Vol 17, Num 5, pp 1915-1931, issn 0305-1048Article

Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growthQUACKENBUSH, E; CLABBY, M; GOTTESDIENER, K. M et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 18, pp 6526-6530, issn 0027-8424Article

Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental painGOTTESDIENER, K; MEHLISCH, D. R; HUNTINGTON, M et al.Clinical therapeutics. 1999, Vol 21, Num 8, pp 1301-1312, issn 0149-2918Article

Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement eventsGOTTESDIENER, K; HUI-MIN CHUNG; BROWN, S. D et al.Molecular and cellular biology (Print). 1991, Vol 11, Num 5, pp 2467-2480, issn 0270-7306Article

Acute effect of ephedrine on 24-h energy balanceSHANNON, J. R; GOTTESDIENER, K; JORDAN, J et al.Clinical science (1979). 1999, Vol 96, Num 5, pp 483-491, issn 0143-5221Article

T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor α, β, or γ genesLEIDEN, J. M; GOTTESDIENER, K. M; KORNBLUTH, J et al.Immunogenetics (New York, NY). 1988, Vol 27, Num 4, pp 231-238, issn 0093-7711Article

Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male VolunteersIANNONE, R; PALCZA, J; RENGER, J. J et al.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 6, pp 831-839, issn 0009-9236, 9 p.Article

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT StudiesBLOOMFIELD, D. M; KOST, J. T; GHOSH, K et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 475-480, issn 0009-9236, 6 p.Article

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1LAI, E; DE LEPELEIRE, I; CRUMLEY, T. M et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 6, pp 849-857, issn 0009-9236, 9 p.Article

Effects of lorazepam on fear- potentiated startle responses in manGRAHAM, S. J; SCAIFE, J. C; LANGLEY, R. W et al.Journal of psychopharmacology (Oxford). 2005, Vol 19, Num 3, pp 249-258, issn 0269-8811, 10 p.Article

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt dietSCHWARTZ, J. I; VANDORMAEL, K; BRUNE, K et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 1, pp 50-61, issn 0009-9236Article

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor AntagonistLAI, E; WENNING, L. A; O'NEILL, G et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 6, pp 840-847, issn 0009-9236, 8 p.Article

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy SubjectsIWAMOTO, M; WENNING, L. A; STONE, J. A et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 2, pp 293-299, issn 0009-9236, 7 p.Article

The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcoholZOETHOUT, Rwm; IANNONE, R; VAN DYCK, K et al.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 2, pp 292-302, issn 0269-8811, 11 p.Article

  • Page / 2